Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Background and aims: Once-weekly insulin analogue offers an advantage by significantly lowering injection frequency of patients with diabetes on basal insulin, which aids in minimizing clinical inertia and enhancing treatment acceptance and adherence, thereby facilitating long-term management of diabetes
First, Swiss Chems places an incredibly high emphasis on the quality and purity of the products they provide, which is often seen to trickle down to the price that customers will eventually pay
JAMA, 314 (7), 687-699
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study
US$ 20.88
US$ 24.32
US$ 26.61
